102 related articles for article (PubMed ID: 33412384)
1. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein.
Saijoh S; Nakamura-Shima M; Shibuya-Takahashi R; Ito R; Sugawara A; Yamazaki T; Imai T; Asada Y; Matsuura K; Iwai W; Wakui Y; Abue M; Kawamura S; Katayose Y; Fujimori H; Mochizuki M; Yasuda J; Yamaguchi K; Sugamura K; Satoh K; Katori Y; Tamai K
Biochem Biophys Res Commun; 2021 Jan; 537():132-139. PubMed ID: 33412384
[TBL] [Abstract][Full Text] [Related]
2. BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Fukushi D; Shibuya-Takahashi R; Mochizuki M; Fujimori H; Kogure T; Sugai T; Iwai W; Wakui Y; Abue M; Murakami K; Nakamura Y; Yasuda J; Yamaguchi K; Sugamura K; Shibata C; Katayose Y; Satoh K; Tamai K
Cancer Sci; 2021 Nov; 112(11):4580-4592. PubMed ID: 34424582
[TBL] [Abstract][Full Text] [Related]
3. BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Tamai K; Nakamura-Shima M; Shibuya-Takahashi R; Kanno SI; Yasui A; Mochizuki M; Iwai W; Wakui Y; Abue M; Yamamoto K; Miura K; Mizuma M; Unno M; Kawamura S; Sato I; Yasuda J; Yamaguchi K; Sugamura K; Satoh K
Sci Rep; 2020 Dec; 10(1):21592. PubMed ID: 33299012
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
5. A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.
Mathews LA; Keller JM; Goodwin BL; Guha R; Shinn P; Mull R; Thomas CJ; de Kluyver RL; Sayers TJ; Ferrer M
J Biomol Screen; 2012 Oct; 17(9):1231-42. PubMed ID: 22927676
[TBL] [Abstract][Full Text] [Related]
6. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
Modi SJ; Kulkarni VM
Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
[TBL] [Abstract][Full Text] [Related]
7. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
9. Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells.
Mu N; Wang Y; Li X; Du Z; Wu Y; Su M; Wang Y; Sun X; Su L; Liu X
Cell Death Dis; 2023 Sep; 14(9):645. PubMed ID: 37777549
[TBL] [Abstract][Full Text] [Related]
10. Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.
Tan Y; Hu Y; Xiao Q; Tang Y; Chen H; He J; Chen L; Jiang K; Wang Z; Yuan Y; Ding K
Int J Biol Sci; 2020; 16(2):228-238. PubMed ID: 31929751
[TBL] [Abstract][Full Text] [Related]
11. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
[TBL] [Abstract][Full Text] [Related]
12. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract][Full Text] [Related]
14. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
15. Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells.
Díaz-Carballo D; Acikelli AH; Bardenheuer W; Gustmann S; Malak S; Stoll R; Kedziorski T; Nazif MA; Jastrow H; Wennemuth G; Dammann P; Feigel M; Strumberg D
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):787-801. PubMed ID: 24902844
[TBL] [Abstract][Full Text] [Related]
16. Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition.
Nie E; Zhang X; Xie S; Shi Q; Hu J; Meng Q; Zhou X; Yu R
Biochem Biophys Res Commun; 2015 Jan; 456(1):494-9. PubMed ID: 25490384
[TBL] [Abstract][Full Text] [Related]
17. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
